TY - JOUR
T1 - Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin
AU - Sherer, Y.
AU - Levy, Y.
AU - Langevitz, P.
AU - Lorber, M.
AU - Fabrizzi, F.
AU - Shoenfeld, Y.
PY - 1999
Y1 - 1999
N2 - Neuropsychiatric lupus includes extremely diverse clinical manifestations, ranging from mild cognitive dysfunction to a severe, life- threatening presentation. We report a 28-year-old patient with systemic lupus erythematosus who had persistent fever for 3 months, and developed within a few hours motor and sensory aphasia, rotator nystagmus with deviation of the eyes, and severe nuchal rigitidy. An extensive series of imaging and laboratory tests were interpreted as normal, except for an elevated opening pressure at lumbar puncture, cerebrospinal fluid inflammatory findings, and asymmetrical cortical perfusion on single-photon emission computed tomography. The patient received one course of high-dose intravenous immunoglobulin (IVIg) and within 5 days her condition returned to that of 3 months before admission. The mechanisms of injury, along with the management of cerebral lupus and the mechanisms of action of IVIg, are discussed.
AB - Neuropsychiatric lupus includes extremely diverse clinical manifestations, ranging from mild cognitive dysfunction to a severe, life- threatening presentation. We report a 28-year-old patient with systemic lupus erythematosus who had persistent fever for 3 months, and developed within a few hours motor and sensory aphasia, rotator nystagmus with deviation of the eyes, and severe nuchal rigitidy. An extensive series of imaging and laboratory tests were interpreted as normal, except for an elevated opening pressure at lumbar puncture, cerebrospinal fluid inflammatory findings, and asymmetrical cortical perfusion on single-photon emission computed tomography. The patient received one course of high-dose intravenous immunoglobulin (IVIg) and within 5 days her condition returned to that of 3 months before admission. The mechanisms of injury, along with the management of cerebral lupus and the mechanisms of action of IVIg, are discussed.
KW - Autoantibodies
KW - Autoimmunity
KW - Intravenous immunoglobulin
KW - Neuropsychiatric lupus
KW - Systemic lupus erythematosus
UR - http://www.scopus.com/inward/record.url?scp=0032903777&partnerID=8YFLogxK
U2 - 10.1007/s100670050079
DO - 10.1007/s100670050079
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0032903777
SN - 0770-3198
VL - 18
SP - 170
EP - 173
JO - Clinical Rheumatology
JF - Clinical Rheumatology
IS - 2
ER -